RT Journal Article
SR Electronic
T1 Acceleration of health deficit accumulation in late-life: Evidence of terminal decline in frailty index three years before death in the US Health and Retirement study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.11.20210732
DO 10.1101/2020.10.11.20210732
A1 Stolz, Erwin
A1 Mayerl, Hannes
A1 Hoogendijk, Emiel O.
A1 Armstrong, Joshua J.
A1 Roller-Wirnsberger, Regina
A1 Freidl, Wolfgang
YR 2020
UL http://medrxiv.org/content/early/2020/10/13/2020.10.11.20210732.abstract
AB Background Little is known about within-person frailty index (FI) changes during the last years of life. In this study, we assess whether there is a phase of accelerated health deficit accumulation (terminal health decline) in late-life.Material and methods 23,393 observations from up to the last 21 years of life of 5,713 deceased participants of the AHEAD cohort in the Health and Retirement Study were assessed. A FI with 32 health deficits was calculated for up to 10 successive biannual assessments (1995-2014), and FI changes according to time-to-death were analyzed with a piecewise linear mixed model with random change points.Results The average normal (pre-terminal) health deficit accumulation rate was 0.01 per year, which increased to 0.05 per year at approximately 3 years before death. Terminal decline began earlier in women and was steeper among men. The accelerated (terminal) rate of health deficit accumulation began at a FI value of 0.29 in the total sample, 0.27 for men, and 0.30 for women.Conclusion We found evidence for an observable terminal health decline in the FI following declining physiological reserves and failing repair mechanisms. Our results suggest a conceptually meaningful cut-off value for the continuous FI around 0.30.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThere was no external funding to this research project.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for the HRS Study was obtained from the University of Michigan Institutional Review Board (HUM00061128, HUM00056464, HUM00002562, HUM00074501, HUM00079949, HUM00080925, HUM00085942, HUM00099822, HUM00103072, HUM00106904, HUM00122335, REP00000046)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesHRS data are freely available to researchers upon registration, and the R-Markdown code reproducing all analyses and results is available online (OSF). https://hrs.isr.umich.edu/data-products https://osf.io/2vhzu/